Lttl research and fine print
Lttl describes itself as a direct-to-consumer telehealth platform, not a pharmacy. The current terms say The Commerce Group Holdings, LLC owns and operates lttl.com. The privacy notice opens by naming Lttl Health, Inc., then its HIPAA section identifies The Commerce Group Holdings, LLC again. This unresolved entity mismatch should be clarified before payment.
Clinical services are attributed to independent U.S.-licensed clinicians and affiliated practices. Lttl names a medical reviewer and advisors on its about page but does not name the medical-group entities or the clinician who would treat a particular patient before intake.
Current terms name four possible pharmacy partners: RedRock Compounding Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx. A prescription may be transferred among pharmacies for fulfillment, availability, pricing, or operational reasons where permitted.
The terms say services are offered in all 50 states plus Washington, D.C., then immediately say some services may not be available in every jurisdiction. Product and pharmacy availability still depends on clinician and pharmacy licensure and the selected treatment.
The public flow begins with an online assessment covering history, medications, lifestyle, and goals. Submission does not itself establish a provider-patient relationship. A clinician may request more information, accept or decline the case, prescribe when appropriate, and use follow-up assessments to monitor and adjust care.
Six cards preserve the most reusable ingredient-and-route identities. Microdose is treated as a dosing protocol, not a therapy. NAD+ oral liquid, MIC+B12, L-carnitine, and methylene blue remain in the narrative rather than forcing new one-provider catalog records.
The selected standard semaglutide table lists $99 for one month, $288 for three, $558 for six, and $1,068 for twelve. Effective monthly rates are $99, $96, $93, and $89. Their unweighted average is $94.25, displayed as Avg. $94/mo.
The selected standard tirzepatide table lists $149 for one month, $438 for three, $858 for six, and $1,668 for twelve. Effective monthly rates are $149, $146, $143, and $139. Their average is $144.25, displayed as Avg. $144/mo.
Lower-dose GLP-1 protocols are not blended into the standard cards. The current microdose tirzepatide table uses $149, $387, $714, and $1,308 across one, three, six, and twelve months. The microdose semaglutide table uses $179, $477, $894, and $1,668. Despite those different tables, both marketing tiles say plans start at $109.
NAD+ injection, NAD+ nasal spray, NAD+ oral liquid, and sermorelin share a displayed schedule of $149 monthly, $417 quarterly, $774 for six months, or $1,188 annually. The effective rates average $129 per month. Distinct routes are not blended into one card.
Glutathione, methylene blue, L-carnitine, and MIC+B12 share a lower schedule of $119 monthly, $297 quarterly, $534 for six months, or $948 annually. Effective rates of $119, $99, $89, and $79 average $96.50 per month, displayed as Avg. $97/mo where a card is appropriate.
Product specifics remain incomplete. The NAD+ injection page advertises 500 to 1,000 mg injections while its FAQ says most patients begin at 100 mg. The nasal and oral NAD+ pages reuse injection wording in their explanatory sections. Exact concentration, volume, frequency, and monthly quantity are not consistently stated.
Sermorelin is presented as a nightly compounded injection. Glutathione is presented as a 200 mg injection, L-carnitine as a 500 mg injection, MIC+B12 as a weekly injection with 1,000 mcg B12, and methylene blue as a low-dose capsule. The final formula, dose, quantity, and pharmacy label must control.
Lttl's own FAQ appropriately says MIC+B12 has not been proven to cause weight loss on its own, L-carnitine evidence varies by use, sermorelin wellness evidence is limited, and oral compounded methylene blue wellness uses are not FDA approved. More assertive benefit headlines elsewhere should not be read as established outcomes.
The site promotes up to $140 off the first month with an automatically applied code, while several product pages say up to $100 off. Complete public eligibility, product, term, stacking, expiry, and affiliate-channel rules were not found, so no promotion appears beneath the review CTA.
Lttl does not bill insurance. It says many patients use HSA or FSA funds, but eligibility depends on the administrator and is not guaranteed. Published plan descriptions include the assessment, clinician review, medication when prescribed, ongoing care access, and shipping.
The insurance page says a customer is charged only after provider review and issuance of a treatment plan, yet it warns that consultation fees may not be refundable if the provider declines. Elsewhere the intake is called free and no-card-required. The amount and trigger of any consultation charge are not public.
Refund language conflicts. Terms promise a full refund after initial medical disqualification unless information was knowingly omitted, but also say a prescription order becomes nonrefundable when the initial intake is submitted. The returns page says consultation fees are generally nonrefundable after provider review even when no prescription is issued.
The terms require written refund requests within 28 days of payment. The returns page gives 30 days to report a billing error. Both pages say processed or shipped prescriptions are generally nonreturnable, and canceling stops future charges rather than refunding prior processed charges.
Subscriptions renew until canceled. The exact billing cadence and cancellation cutoff are disclosed at checkout or in the account, not in the public terms. Cancellation is available in account settings or by emailing hello@lttl.com and must occur before the operative cutoff and pharmacy processing.
The terms include individual JAMS arbitration, a class-action and jury waiver, a one-year claim deadline, Delaware governing law, and a liability cap generally set at the greater of $100 or the amount paid in the preceding 12 months.
The shipping page says most pharmacy processing takes 2 to 5 business days and standard transit takes another 3 to 7 business days. That detailed timeline conflicts with banners saying prescribed and shipped within 48 hours and product pages saying free shipping arrives in 1 to 2 days.
Temperature-sensitive medication is shipped with cold-chain packaging where required. Patients are told to refrigerate promptly and not use visibly damaged, leaking, or compromised medication. Lttl gives a contact path but does not promise a specific replacement or reshipment remedy.
Support includes hello@lttl.com with a stated reply within one business day and (888) 847-7806 staffed Monday through Friday from 8 a.m. to 8 p.m. Eastern. Portal care chat is available for clinical questions.
Footer language about 24/7 support is interpreted as portal access, not guaranteed live staffing. The contact page publishes narrower phone hours and no round-the-clock clinical response target. Emergency care is explicitly excluded.
The privacy notice covers contact, health, device, cookie, advertising, and consumer-health data. It says AI and machine-learning tools may analyze health information to improve services, clinical workflows, and AI systems under applicable rules. It provides privacy and HIPAA contact emails but no general deletion completion target.
Lttl displays a current-year Forbes Health's Best Provider banner. The current Forbes Health best online GLP-1 provider ranking reviewed for this draft lists six other services and contains no Lttl entry. The award claim is therefore not treated as verified.
The current claimed Trustpilot profile showed a 4.3 TrustScore from nine reviews during research. That small external sample does not validate the 100,000-plus or 125,000-plus customer claims repeated on Lttl product pages, so no user rating or customer count is imported into AllyRx.
Lttl presents a LegitScript certification badge linked to LegitScript's checker. The checker loaded but required reCAPTCHA and did not return a readable domain result during this pass. The certification remains provider-presented rather than independently confirmed.
Compounded drugs are not FDA approved and do not undergo FDA premarket review for safety, effectiveness, or quality. FDA currently warns telehealth companies against misleading compounded-drug promotion and highlights GLP-1 dosing, salt-form, quality, and temperature concerns. No FDA warning letter to Lttl was identified in this review.
FDA has separately warned sterile compounders to use drug-suitable NAD+ and glutathione ingredients. These are general safety and source-verification issues, not evidence that one of Lttl's named pharmacies violated a requirement.
Katalys program 1619 remains pending in AllyRx's internal record, with no issued tracking URL or verified affiliate promotion. The local CTA therefore uses lttl.com directly. Recorded payout and EPC affected research order only and did not affect the score, verdict, or catalog decisions.
- Six normalized ingredient-and-route cards avoid counting lower-dose protocols as new therapies.
- Four-term plan tables produce compact monthly averages while retaining every prepaid total.
- Four partner pharmacies and broad geographic availability are disclosed.
- Refund pages conflict on medical decline, consultation charges, processing, and deadlines.
- Detailed shipping timing conflicts with faster marketing banners.
- Legal pages alternate between two operating entities.
- The reviewed Forbes Health ranking does not support Lttl's award banner.
- Public support channels are unusually clear, including response timing and phone hours.